KalVista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.
Location: United States, Massachusetts, Cambridge
Member count: 51-200
Total raised: $46.204828M
Founded date: 2004
Investors 4
Date | Name | Website |
- | InterWest ... | interwest.... |
- | RA Capital... | racap.com |
- | Technology... | pivotcente... |
- | Vivo Capit... | vivocapita... |
Funding Rounds 2
Date | Series | Amount | Investors | Deal News |
22.07.2015 | Series B | $33M | - | finsmes.co... |
23.08.2011 | Series A | $13.204828... | - | finsmes.co... |
Mentions in press and media 9
Date | Title | Description | Category | Author | Source |
27.10.2022 | KalVista P... | KalVista today announced the a... | - | - | einpresswi... |
08.01.2022 | KalVista P... | Corporate Overview January 20... | - | - | marketscre... |
16.11.2021 | KalVista P... | Corporate Presentation Novemb... | - | - | marketscre... |
09.09.2021 | KalVista P... | Corporate Presentation Septem... | - | - | marketscre... |
19.03.2021 | KalVista P... | CAMBRIDGE, Mass. & SALISBU... | - | - | oaoa.com/n... |
11.03.2021 | KalVista P... | CAMBRIDGE, Mass. & SALISBU... | - | - | oaoa.com/n... |
22.07.2015 | Daily fund... | Events.com has now raised a to... | - | Mitos Suso... | vator.tv/n... |
22.07.2015 | KalVista P... | KalVista Pharmaceuticals, a Po... | UK | - | finsmes.co... |
23.08.2011 | KalVista P... | KalVista Pharmaceuticals, a So... | funding S... | - | finsmes.co... |